Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
The Chosun Ilbo on MSN
14.2 million COVID-19 vaccines with foreign substances administered
Foreign substances such as mold, hair, and silicon dioxide (silica) were found in COVID-19 vaccines, potentially introduced ...
Many readers are incensed that federal health officials may go after vaccines containing minuscule amounts of aluminum salts.
NEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe ...
For our latest UPC update, we report on recent developments, including an expansion of GSK’s COVID-19 vaccine claim against Moderna and a ruling that offers hope for litigation insurance. A new claim ...
US mRNA specialist Moderna today announced that the European Commission (EC) has granted marketing authorization for mNEXSPIKE (mRNA-1283), a new COVID vaccine, for active immunization to prevent ...
In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.
Union Health Minister J.P. Nadda launched India's indigenously manufactured tetanus and adult diphtheria (Td) vaccine, ...
Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.
Union Health Minister JP Nadda on Saturday launched the indigenously manufactured Tetanus and Adult Diphtheria (Td) vaccine at the Central Research Institute in Himachal Pradesh, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results